PMC:7358770 / 14864-15025 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T169","span":{"begin":70,"end":76},"obj":"Body_part"}],"attributes":[{"id":"A169","pred":"fma_id","subj":"T169","obj":"http://purl.org/sig/ont/fma/fma228738"}],"text":"tion process, and are a promising therapy against viral infections of throat [67]. The cationically modified chitosan, N-(2-hydroxypropyl)-3-trimethylammonium ch"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T3","span":{"begin":70,"end":76},"obj":"Body_part"}],"attributes":[{"id":"A3","pred":"uberon_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/UBERON_0000341"}],"text":"tion process, and are a promising therapy against viral infections of throat [67]. The cationically modified chitosan, N-(2-hydroxypropyl)-3-trimethylammonium ch"}

{"project":"LitCovid-PubTator","denotations":[{"id":"551","span":{"begin":50,"end":66},"obj":"Disease"}],"attributes":[{"id":"A551","pred":"tao:has_database_id","subj":"551","obj":"MESH:D001102"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"tion process, and are a promising therapy against viral infections of throat [67]. The cationically modified chitosan, N-(2-hydroxypropyl)-3-trimethylammonium ch"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T50","span":{"begin":50,"end":66},"obj":"Disease"}],"attributes":[{"id":"A50","pred":"mondo_id","subj":"T50","obj":"http://purl.obolibrary.org/obo/MONDO_0005108"}],"text":"tion process, and are a promising therapy against viral infections of throat [67]. The cationically modified chitosan, N-(2-hydroxypropyl)-3-trimethylammonium ch"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T133","span":{"begin":22,"end":23},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"tion process, and are a promising therapy against viral infections of throat [67]. The cationically modified chitosan, N-(2-hydroxypropyl)-3-trimethylammonium ch"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T263","span":{"begin":109,"end":117},"obj":"Chemical"},{"id":"T265","span":{"begin":141,"end":158},"obj":"Chemical"}],"attributes":[{"id":"A263","pred":"chebi_id","subj":"T263","obj":"http://purl.obolibrary.org/obo/CHEBI_16261"},{"id":"A264","pred":"chebi_id","subj":"T263","obj":"http://purl.obolibrary.org/obo/CHEBI_57704"},{"id":"A265","pred":"chebi_id","subj":"T265","obj":"http://purl.obolibrary.org/obo/CHEBI_58389"}],"text":"tion process, and are a promising therapy against viral infections of throat [67]. The cationically modified chitosan, N-(2-hydroxypropyl)-3-trimethylammonium ch"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T12","span":{"begin":50,"end":66},"obj":"http://purl.obolibrary.org/obo/GO_0016032"}],"text":"tion process, and are a promising therapy against viral infections of throat [67]. The cationically modified chitosan, N-(2-hydroxypropyl)-3-trimethylammonium ch"}

{"project":"2_test","denotations":[{"id":"32679328-28280379-48281282","span":{"begin":78,"end":80},"obj":"28280379"},{"id":"T66604","span":{"begin":78,"end":80},"obj":"28280379"}],"text":"tion process, and are a promising therapy against viral infections of throat [67]. The cationically modified chitosan, N-(2-hydroxypropyl)-3-trimethylammonium ch"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T399","span":{"begin":50,"end":55},"obj":"NCBITaxon:10239"},{"id":"T400","span":{"begin":70,"end":76},"obj":"UBERON:0000341"},{"id":"T401","span":{"begin":87,"end":99},"obj":"CHEBI:36916;CHEBI:36916"},{"id":"T402","span":{"begin":109,"end":117},"obj":"CHEBI:16261;CHEBI:16261"},{"id":"T403","span":{"begin":119,"end":121},"obj":"CHEBI:8502;CHEBI:8502"},{"id":"T404","span":{"begin":121,"end":122},"obj":"CHEBI:62946;CHEBI:62946"},{"id":"T405","span":{"begin":122,"end":123},"obj":"CHEBI:86228;CHEBI:86228"},{"id":"T406","span":{"begin":123,"end":137},"obj":"CHEBI:20067;CHEBI:20067"},{"id":"T407","span":{"begin":139,"end":141},"obj":"CHEBI:53233;CHEBI:53233"},{"id":"T408","span":{"begin":141,"end":158},"obj":"CHEBI:58389;CHEBI:58389"},{"id":"T22385","span":{"begin":16,"end":21},"obj":"NCBITaxon:10239"},{"id":"T29049","span":{"begin":98,"end":102},"obj":"SP_10"},{"id":"T9086","span":{"begin":148,"end":157},"obj":"UBERON:0002048"}],"text":"tion process, and are a promising therapy against viral infections of throat [67]. The cationically modified chitosan, N-(2-hydroxypropyl)-3-trimethylammonium ch"}

{"project":"MyTest","denotations":[{"id":"551","span":{"begin":50,"end":66},"obj":"Disease"}],"attributes":[{"id":"A551","pred":"tao:has_database_id","subj":"551","obj":"MESH:D001102"}],"namespaces":[{"prefix":"_base","uri":"https://www.uniprot.org/uniprot/testbase"},{"prefix":"UniProtKB","uri":"https://www.uniprot.org/uniprot/"},{"prefix":"uniprot","uri":"https://www.uniprot.org/uniprotkb/"}],"text":"tion process, and are a promising therapy against viral infections of throat [67]. The cationically modified chitosan, N-(2-hydroxypropyl)-3-trimethylammonium ch"}